Skip to content
  • Home
  • Resources
    • Azurity Solutions
    • E-Z Rx®
    • Patient Direct
    • Patient Support
    • News & Events
    • Compliance
    • Medical Information
    • Careers
  • Contact Us
Azurity Pharmaceuticals
  • Company
    • About Us
    • Management Team
    • Board of Directors
  • Products
    • Products
    • Cardiovascular
      • BiDil®
      • Edarbi®
      • Edarbyclor®
      • Epaned ®
      • Katerzia®
      • Qbrelis®
    • Central Nervous System
      • EPRONTIA™
      • Evekeo®
      • Evekeo ODT®
      • FLEQSUVY™
      • Horizant®
      • Zenzedi®
      • ZONISADETM
    • Endocrinology
      • Triptodur®
    • Gastrointestinal
      • KONVOMEP™
    • Institutional / Orphan
      • FIRVANQ® (Anti-Infective)
      • Gliadel® Wafer (Oncology, Implantable Device)
      • Nymalize®
      • Sotylize®
      • Xatmep® (Oncology, Rheumatology)
    • Certain products listed may be owned by a subsidiary of Azurity Pharmaceuticals.
  • Pipeline
  • Compounding Kits
    • Compounding Kits
    • FIRST® – Lansoprazole
    • FIRST® – Omeprazole
    • FIRST® – BLM Mouthwash
    • FIRST® – Metronidazole
    • FIRST® – Progesterone
Select Page

Arbor Supports Updated Clinical Recommendations for Restless Legs Syndrome

by GOT | Sep 1, 2021 | Legacy Arbor Archives

Arbor Supports Updated Clinical Recommendations for Restless Legs Syndrome Arbor has long recognized the need for effective treatment options for Restless Legs Syndrome (RLS) and support for the patients who suffer from it. We are pleased to support The Updated...

Arbor Pharmaceuticals, LLC Confirms Availability of Triptodur® (triptorelin) for Patients with Central Precocious Puberty

by GOT | Aug 27, 2020 | Legacy Arbor Archives

Arbor Pharmaceuticals, LLC Confirms Availability of Triptodur® (triptorelin) for Patients with Central Precocious Puberty Company orders additional product amid reported industry shortage ATLANTA, Aug. 25, 2020 – Arbor Pharmaceuticals, LLC, a U.S.-based specialty...

Recent Posts

  • Dual Monitor Tools Discussion Help: How to trigger “A generic error has occured in GDI+”
  • How to set Acrobat Reader DC or Acrobat DC your default PDF program on Windows 10
  • How to Open HEIC Photos in Windows 10 Photos App
  • How To Fix Windows 10 Errors
  • Best 3 Methods to Take Screenshots on Windows 10

Recent Comments

    Archives

    • September 2022
    • August 2022
    • July 2022
    • June 2022
    • February 2022
    • November 2021
    • September 2021
    • August 2021
    • February 2021
    • August 2020
    • July 2019
    • June 2019
    • April 2018
    • March 2018
    • January 2018

    Categories

    • 1pinupbet.uz
    • 1xslots-online.com
    • bet-online-in.com#parimatch-india#
    • CutisPharma Press Releases
    • Dating Online
    • Dll-Files
    • kings-chance-play.com#login#
    • Legacy Arbor Archives
    • leon-betting.ru
    • leovegas-online.com#en#
    • ligastavok-liga.ru#rfpl#
    • News
    • Uncategorized
    • vulkanroyall.com

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Home

    Pipeline

    Contact Us

    Company

    • About Us
    • Management Team
    • Board of Directors
    • Follow
    • Follow

    Products

    • BiDil®
    • Edarbi®
    • Edarbyclor®
    • Epaned®
    • EPRONTIA™
    • Evekeo®
    • Evekeo ODT®
    • Firvanq®
    • FLEQSUVY™
    • Gliadel® Wafer
    • Horizant®
    • Katerzia®
    • KONVOMEPTM
    • Nymalize®
    • Qbrelis®
    • Sotylize®
    • Triptodur®
    • Xatmep®
    • Zenzedi®
    • ZonisadeTM

    Compounding Kits

    • FIRST® – Lansoprazole
    • FIRST® – Omeprazole
    • FIRST® – BLM Mouthwash
    • FIRST® – Metronidazole
    • FIRST® – Progesterone

    Resources

    • Azurity Solutions
    • E-Z Rx®
    • Patient Direct
    • Patient Assistance
    • News & Events
    • Compliance
    • Medical Information
    • Careers
    • Terms of Use
    • Privacy Policy and Cookie Notice
    • Web Accessibility Policy

    Azurity Pharmaceuticals, Inc. was formerly known as CutisPharma, Inc., parent company of Silvergate Pharmaceuticals, Inc. Product labeling, packaging, and imagery are for representation purposes only and shall constitute the property of Azurity and all applicable affiliates.

    The Information contained herein, including product information, is intended only for residents of the United States.

    © 2019 – 2022 Azurity Pharmaceuticals, Inc. All Rights Reserved. All Trademarks referred to are the property of their respective owners. PP-KON-US-0008
    AZ_Logo_White
    ADA Site Compliance-Accessibility Policy